Oncotarget

Research Papers:

Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers

Yali Zhong, Xiaoli Li, Yasai Ji, Xiaoran Li, Yaqing Li, Dandan Yu, Yuan Yuan, Jian Liu, Huixiang Li, Mingzhi Zhang, Zhenyu Ji, Dandan Fan, Jianguo Wen, Mariusz Adam Goscinski, Long Yuan, Bin Hao, Jahn M Nesland and Zhenhe Suo _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:13344-13356. https://doi.org/10.18632/oncotarget.14527

Metrics: PDF 1921 views  |   HTML 3027 views  |   ?  


Abstract

Yali Zhong1,2,3,4, Xiaoli Li1, Yasai Ji1, Xiaoran Li3,4, Yaqing Li1, Dandan Yu1, Yuan Yuan5, Jian Liu6, Huixiang Li7, Mingzhi Zhang1, Zhenyu Ji8, Dandan Fan8, Jianguo Wen9, Mariusz Adam Goscinski10, Long Yuan11, Bin Hao12, Jahn M Nesland3,4, Zhenhe Suo1,3,4

1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China

2Department of Gastroenterology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China

3Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Montebello, Oslo, Norway

4Department of Pathology, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

5Department of Pathology, Capital Medical University, Beijing, China

6Institute of Health Quarantine, Chinese Academy of Inspection and Quarantine, Beijing, China

7Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China

8Henan Academy of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou

9Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Henan, China

10Department of Surgery, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

11Department of Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China

12Department of Urology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

Correspondence to:

Zhenhe Suo, email: [email protected]

Keywords: PDHA1, glycolysis, stemness, prostate cancer

Received: September 30, 2016     Accepted: December 28, 2016     Published: January 05, 2017

ABSTRACT

Cells generate adenosine-5′-triphosphate (ATP), the major currency for energy-consuming reactions, through mitochondrial oxidative phosphorylation (OXPHOS) and glycolysis. One of the remarkable features of cancer cells is aerobic glycolysis, also known as the “Warburg Effect”, in which cancer cells rely preferentially on glycolysis instead of mitochondrial OXPHOS as the main energy source even in the presence of high oxygen tension. One of the main players in controlling OXPHOS is the mitochondrial gatekeeperpyruvate dehydrogenase complex (PDHc) and its major subunit is E1α (PDHA1). To further analyze the function of PDHA1 in cancer cells, it was knock out (KO) in the human prostate cancer cell line LnCap and a stable KO cell line was established. We demonstrated that PDHA1 gene KO significantly decreased mitochondrial OXPHOS and promoted anaerobic glycolysis, accompanied with higher stemness phenotype including resistance to chemotherapy, enhanced migration ability and increased expression of cancer stem cell markers. We also examined PDHA1 protein expression in prostate cancer tissues by immunohistochemistry and observed that reduced PDHA1 protein expression in clinical prostate carcinomas was significantly correlated with poor prognosis. Collectively, our results show that negative PDHA1 gene expressionis associated with significantly higher cell stemness in prostate cancer cells and reduced protein expression of this gene is associated with shorter clinical outcome in prostate cancers.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14527